EIF2AK4 rs16970024: Stress Response Genetics Explained
The rs16970024 single nucleotide polymorphism is an intronic variant mapped to the EIF2AK4 gene on chromosome 15. EIF2AK4 encodes the stress-sensing kinase GCN2, an essential regulator of the cellular integrated stress response during amino acid deprivation. Research suggests rs16970024 may influence GCN2 expression and cellular resilience under metabolic stress, though current direct scientific evidence remains limited.
What each genotype means
Typical stress response
You carry two copies of the major C allele for this variant in the EIF2AK4 gene, which encodes the cellular stress-sensing kinase GCN2. Research suggests that this genotype is associated with standard baseline expression and typical activation of the integrated stress response during nutrient deprivation. Current evidence evaluating subtle metabolic or stress-response differences for this specific variant remains limited.
Carried by approximately 55% to 60% of individuals across diverse global populations.
Altered stress response potential
You carry one copy of the minor T allele and one copy of the C allele in the EIF2AK4 gene. Preliminary studies suggest that this variant may modestly influence the integrated stress response pathway governed by the GCN2 kinase during metabolic stress. However, clinical and physiological evidence for this specific common polymorphism is currently limited, and it is not considered diagnostic of any medical condition.
Carried by approximately 35% to 40% of people globally, reflecting a minor allele frequency of roughly 0.24.
Modulated stress response profile
You carry two copies of the minor T allele in the EIF2AK4 gene, which regulates how cells adapt to amino acid and metabolic stress via the integrated stress response. While carrying two copies of this variant is common in the general population, published research on its standalone physiological effects remains limited and preliminary. This genotype does not cause known severe Mendelian disorders associated with rare loss-of-function EIF2AK4 mutations.
Carried by roughly 5% to 7% of individuals across major continental populations.
Genomic Location and the EIF2AK4 Gene
The single nucleotide polymorphism rs16970024 resides within an intronic region of the EIF2AK4 gene, located on chromosome 15 (15q15.1). EIF2AK4 encodes eukaryotic translation initiation factor 2 alpha kinase 4, historically known as GCN2 (general control nonderepressible 2). Rather than modifying the amino acid sequence of the resulting protein, non-coding variations like rs16970024 frequently function as expression quantitative trait loci (eQTLs) or regulatory elements that fine-tune how readily the gene is transcribed. GCN2 is expressed across numerous tissues throughout the human body, where it acts as a molecular sentinel. Because this variant sits in an intron, its primary biological influence is thought to stem from modest modulation of EIF2AK4 messenger RNA abundance or splicing dynamics, rather than complete loss or structural disruption of the kinase.
Biological Role: The Integrated Stress Response and GCN2
Cells depend on a tightly orchestrated signaling network known as the integrated stress response (ISR) to survive fluctuations in nutrient availability and metabolic stress. GCN2 is one of four specialized kinases that initiate this pathway. It features a regulatory domain capable of binding uncharged transfer RNAs (tRNAs), which accumulate when cellular pools of amino acids drop. When activated by uncharged tRNAs or metabolic deprivation, GCN2 phosphorylates the alpha subunit of eukaryotic initiation factor 2 (eIF2-alpha). This phosphorylation transiently halts general protein synthesis to conserve cellular energy and resources, while simultaneously promoting the preferential translation of transcription factors like ATF4. Downstream of ATF4, the cell activates programs for amino acid synthesis, transport, and oxidative stress resistance, restoring homeostatic balance.
Current Research and Strength of Evidence
Scientific evidence directly connecting rs16970024 to specific human clinical phenotypes is currently categorized as limited. While severe, biallelic loss-of-function mutations in EIF2AK4 are definitively linked to rare, life-threatening conditions such as pulmonary veno-occlusive disease 2 (PVOD2) and pulmonary capillary hemangiomatosis, common variants like rs16970024 exert subtle quantitative effects. Preliminary functional mapping and expression studies suggest that alleles at this locus may modulate baseline or stress-induced GCN2 expression. However, large-scale genome-wide association studies (GWAS) have not established definitive, reproducible ties between rs16970024 and common metabolic, cardiovascular, or inflammatory diseases. Any observed associations in population studies represent modest statistical correlations rather than direct clinical determinants.
Interpreting Your Genetic Results
Discovering your rs16970024 genotype provides interesting insight into how common variations exist within fundamental cellular survival pathways, but it cannot be used as a clinical diagnostic tool. Carrying a variant allele does not mean an individual has a dysfunctional stress response, nor does it diagnose metabolic illness, dietary intolerance, or pulmonary vascular conditions. Genetic resilience to physiological stress is inherently polygenic and strongly influenced by diet, exercise, and environmental exposures. This genotype should be treated as educational context rather than actionable medical information. Furthermore, individuals should never alter their dietary intake, fast aggressively, or adjust prescription medications based on EIF2AK4 single nucleotide polymorphisms without personalized guidance from a physician or genetic counselor.
How common is this variant?
The minor allele for rs16970024 exhibits an estimated frequency of approximately 0.24 across diverse global populations, indicating that heterozygous and homozygous minor genotypes are widely distributed in healthy individuals.
Frequently asked questions
What does the EIF2AK4 gene do in the body?
EIF2AK4 produces the GCN2 kinase, an enzyme that detects nutrient starvation—specifically low amino acid levels—inside human cells. When triggered, it initiates the integrated stress response to temporarily pause energy-intensive protein manufacturing and boost cellular survival mechanisms.
Does having a variant at rs16970024 cause disease?
No, rs16970024 is not a pathogenic mutation. While rare, destructive mutations in EIF2AK4 can cause severe disorders like pulmonary veno-occlusive disease, rs16970024 is a common polymorphism present in millions of healthy people and has not been proven to cause clinical illness.
Can rs16970024 tell me what diet or supplements I should take?
No. Despite GCN2's biological role in amino acid sensing, there is no clinical research showing that individuals with specific rs16970024 genotypes benefit from tailored protein intakes, specific amino acid supplements, or specialized diets. Nutritional needs should always be guided by comprehensive lifestyle evaluation and healthcare professionals.
Why is the evidence for rs16970024 described as limited?
Although laboratory experiments show how the broader GCN2 pathway functions, large-scale clinical studies and genome-wide association studies have not confirmed strong or consistent clinical phenotypes specifically tied to rs16970024. Consequently, researchers treat its phenotypic effects as speculative and modest.
Sources & further reading
Educational information only, last refreshed 9/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs16970024?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29